Xbrane Biopharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	86.59	124.33	65.4	193.99	295.18
Cash & Short-Term Investments	86.59	124.33	65.4	193.99	295.18
Cash Growth	-30.36%	90.10%	-66.29%	-34.28%	21.40%
Accounts Receivable	6.74	16.85	-	1.34	-
Other Receivables	5.56	76.01	71.18	46.12	108.3
Receivables	12.3	92.87	71.18	47.46	108.3
Inventory	194.27	246.9	106.86	50.26	-
Prepaid Expenses	81.5	8.07	16.89	13	2.31
Other Current Assets	0.47	133.73	201.37	208.81	155.21
Total Current Assets	375.13	605.9	461.69	513.52	561.01
Property, Plant & Equipment	0.04	64.9	88.2	71.05	73.8
Other Intangible Assets	296.46	-	-	-	-
Long-Term Deferred Charges	-	167.69	99.67	102	49.67
Other Long-Term Assets	-	3.95	3.95	3.95	3.95
Total Assets	671.62	842.43	653.51	690.52	688.43
Accounts Payable	8.96	242.57	30.97	23.3	41.39
Accrued Expenses	36.19	41.19	140.89	66.48	65.76
Current Portion of Long-Term Debt	-	82.5	62.5	-	-
Current Portion of Leases	-	13.27	13.37	9.16	7.91
Current Unearned Revenue	-	147.26	75.41	136.06	95.39
Other Current Liabilities	7.52	11.15	3.42	1.56	9.22
Total Current Liabilities	52.66	537.94	326.56	236.57	219.67
Long-Term Debt	58.31	66.37	112.9	-	-
Long-Term Leases	-	29.58	42.71	29.06	36.48
Long-Term Unearned Revenue	-	-	-	-	0.54
Other Long-Term Liabilities	-	-0	0.01	-	-
Total Liabilities	110.97	633.89	482.17	265.63	256.69
Common Stock	2.06	343.5	6.68	6.17	5.61
Additional Paid-In Capital	1,386	1,395	1,429	1,294	1,134
Retained Earnings	-837.61	-1,540	-1,274	-885.83	-713.31
Comprehensive Income & Other	10.11	10.23	10.12	10.32	5.16
Shareholders' Equity	560.65	208.54	171.34	424.89	431.74
Total Liabilities & Equity	671.62	842.43	653.51	690.52	688.43
Total Debt	58.31	191.72	231.48	38.22	44.38
Net Cash (Debt)	28.28	-67.39	-166.08	155.77	250.8
Net Cash Growth	-	-	-	-37.89%	5.88%
Net Cash Per Share	0.02	-6.85	-723.19	761.51	1328.76
Filing Date Shares Outstanding	464.96	12.24	0.24	0.22	0.2
Total Common Shares Outstanding	464.96	12.24	0.24	0.22	0.2
Working Capital	322.47	67.96	135.14	276.96	341.34
Book Value Per Share	1.21	17.04	718.44	1930.89	2155.27
Tangible Book Value	264.19	208.54	171.34	424.89	431.74
Tangible Book Value Per Share	0.57	17.04	718.44	1930.89	2155.27
Machinery	-	62.43	61.93	-	43.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.